Renovacor raises $11 mln
Renovacor said Aug. 14 that it raised $11 million in a Series A co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined by New Leaf Venture Partners and Innogest Capital. Renovacor is a preclinical-stage biopharmaceutical company focused on developing gene therapy-based treatments for cardiovascular disease.
14 August 2019•5 mins read
